CBAY

Q: What is the price of CymaBay Therapeutics (CBAY) today?

The current price of CymaBay Therapeutics (CBAY) is $ 0.00, representing a 0% gain over the past year. The stock began the year trading around $ 0.00 and is currently priced at $ 0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does CymaBay Therapeutics (CBAY) pay dividends?

CymaBay Therapeutics (CBAY) did not pay dividends over the past year.

CymaBay Therapeutics Inc.

This asset is no longer available for investment.

View all assets

Price

$ -

return (12m)

0.00%

p/e

-34.99

p/bv

13.22

DIVIDEND YIELD

0.00%

CBAY price

CBAY

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

15 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment CBAY

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals CBAY

review the fundamentals of CymaBay Therapeutics shares

P/E

-34.99

Sector: -1.37 Industry: 11.03

P/S (PSR)

124.36

Sector: 1.93 Industry: 1.54

P/BV

13.22

Sector: 2.08 Industry: 3.18

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: 0.01%

ROA

-25.41%

Sector: -26.93% Industry: 3.04%

ROE

-37.80%

Sector: -32.98% Industry: 7.23%

ROIC

-544.54%

Sector: -433.14% Industry: -4.08%

NET MARGIN

-100.00%

Sector: -29.12% Industry: 2.71%

GROSS MARGIN

100.00%

Sector: 45.58% Industry: 30.10%

OPERATING MARGIN

-100.00%

Sector: -23.85% Industry: 2.09%

EV/EBITDA

-41.12

Sector: 0.05 Industry: 7.65

EV/EBIT

-40.82

Sector: -1.20 Industry: 5.96

PRICE-TO-ASSETS

8.89

Sector: 1.14 Industry: 1.45

BVPS

2.46

Sector: 3.93 Industry: 14.79

EPS

-0.93

Sector: -0.90 Industry: 1.10

EQUITY-TO-ASSETS RATIO

0.67

Sector: 0.44 Industry: 0.46

LIABILITIES / ASSETS

0.67

Sector: 0.47 Industry: 0.52

CAGR REVENUE 5 YEARS

0.00%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

3.20%

Sector: - Industry: -

Fundamentals CBAY

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	34.89	28.27	81.02%	0.63%	$ 881.85 B	34.99%
ISRG	52.42	8.87	16.93%	0.00%	$ 156.17 B	28.15%
TMO	24.01	3.16	13.15%	0.40%	$ 164.42 B	15.15%
SNY	6.85	1.22	17.79%	5.28%	$ 102.25 B	14.75%
NVS	21.04	7.31	34.77%	2.08%	$ 284.73 B	23.92%
ABT	24.34	0.00	-%	2.78%	$ 152.79 B	13.91%
MDT	21.50	2.02	9.38%	3.67%	$ 99.20 B	13.00%
GSK	12.78	4.32	33.77%	3.52%	$ 100.27 B	17.79%
CVS	41.68	1.57	3.78%	2.77%	$ 122.20 B	0.72%
BSX	23.45	3.23	13.78%	0.00%	$ 83.60 B	17.29%
TMDX	13.51	4.70	34.80%	0.00%	$ 2.32 B	27.04%
HCA	13.94	-31.80	-228.14%	0.70%	$ 94.70 B	8.89%
IDXX	39.87	28.06	70.38%	0.00%	$ 43.66 B	24.63%
RMD	19.42	4.55	23.41%	1.14%	$ 29.51 B	27.44%
DHR	31.37	2.19	6.97%	0.83%	$ 115.73 B	14.89%
INMD	10.19	1.34	13.18%	0.00%	$ 888.30 M	23.27%
PHG	21.11	1.81	8.56%	3.54%	$ 23.86 B	5.50%
SYK	35.85	5.21	14.52%	1.10%	$ 119.63 B	13.21%
FMS	10.79	0.72	6.71%	3.64%	$ 11.88 B	4.89%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*The value considers the reinvestment of dividends.

CBAY Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT CymaBay Therapeutics

CymaBay Therapeutics Inc.

Average Investor10 user rating

4.0 (2 people)

United States

38 years

Founded: 1988

2014

Time since IPO - 12 years

44

Employees

CymaBay Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $3.87 Billions, with shareholders equity totaling $292.26 Millions.

The company employs approximately 44 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, CymaBay Therapeutics Inc. reported $31.08 Millions in revenue, generating net income of $-105.37 Millions.

Key financial metrics include a P/E ratio of -34.99, a price-to-book (P/B) ratio of 13.22, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker CBAY.

Market cap

$ 3.87 Billions

Net worth

$ 292.26 Millions

$ 292,260,000.00

Assets

$ 434.69 Millions

$ 434,690,000.00

Total Shares Outstanding

119.00 Millions

119,000,000

Average Daily Trading Volume

$ 4.43 Millions

$ 4,427,424.06

Sector

Health

Industry

Pharmaceutical Products

CBAY

CBAY revenue and profits

Financial Results CBAY

DRAG THE FRAME TO SEE MORE DATA

CBAY cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

CI - Cigna

$ 283.10 --7,05% (12M)

P/E

18.85

2.14%

ROE

18.71%

P/BV

3.53

CVS - CVS Health

$ 93.28 60,54% (12M)

P/E

41.68

2.77%

ROE

3.78%

P/BV

1.57

CNC - Centene

$ 58.28 0,36% (12M)

P/E

-4.45

0.00%

ROE

-29.93%

P/BV

1.33

HUM - Humana

$ 304.10 36,39% (12M)

P/E

32.40

1.16%

ROE

6.06%

P/BV

1.96

SNY - Sanofi

$ 44.67 --7,67% (12M)

P/E

6.85

5.28%

ROE

17.79%

P/BV

1.22

LLY - Eli Lilly

$ 1,018.87 43,77% (12M)

P/E

34.89

0.63%

ROE

81.02%

P/BV

28.27

HCA - HCA Healthcare

$ 396.67 6,22% (12M)

P/E

13.94

0.70%

ROE

-228.14%

P/BV

-31.80

NVS - Novartis

$ 150.45 36,33% (12M)

P/E

21.04

2.08%

ROE

34.77%

P/BV

7.31

CI - Cigna

$ 283.10 --7,05% (12 M)

P/L

18.85

2.14%

ROE

18.71%

P/VP

3.53

CVS - CVS Health

$ 93.28 60,54% (12 M)

P/L

41.68

2.77%

ROE

3.78%

P/VP

1.57

CNC - Centene

$ 58.28 0,36% (12 M)

P/L

-4.45

0.00%

ROE

-29.93%

P/VP

1.33

HUM - Humana

$ 304.10 36,39% (12 M)

P/L

32.40

1.16%

ROE

6.06%

P/VP

1.96

SNY - Sanofi

$ 44.67 --7,67% (12 M)

P/L

6.85

5.28%

ROE

17.79%

P/VP

1.22

LLY - Eli Lilly

$ 1,018.87 43,77% (12 M)

P/L

34.89

0.63%

ROE

81.02%

P/VP

28.27

HCA - HCA Healthcare

$ 396.67 6,22% (12 M)

P/L

13.94

0.70%

ROE

-228.14%

P/VP

-31.80

NVS - Novartis

$ 150.45 36,33% (12 M)

P/L

21.04

2.08%

ROE

34.77%

P/VP

7.31

Frequently Asked Questions

What is the price of CymaBay Therapeutics (CBAY) today?

The current price of CymaBay Therapeutics (CBAY) is $ 0.00, representing a 0% gain over the past year. The stock began the year trading around $ 0.00 and is currently priced at $ 0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does CymaBay Therapeutics (CBAY) pay dividends?

CymaBay Therapeutics (CBAY) did not pay dividends over the past year.

Is CymaBay Therapeutics (CBAY) a good investment?

CymaBay Therapeutics (CBAY) is currently trading at $ 0.00 with a P/E ratio of -34.99. This represents a -2,018% premium compared to its historical average P/E. Over the past year, the stock has gained 0 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy CymaBay Therapeutics (CBAY) stock?

You can buy CymaBay Therapeutics (CBAY) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol CBAY and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of CymaBay Therapeutics (CBAY) yield today?

Over the past month, CymaBay Therapeutics (CBAY) has returned 0.00% — 0.00% over the past year, and 0.00% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of CymaBay Therapeutics (CBAY) today at the current price of $ 0.00 your total investment would be $ 0.00.

Based on historical performance, the investment would have grown to approximately:

$ 0.00 after 1 year
$ 0.00 after 5 years
$ 0.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

CBAY

CymaBay Therapeutics Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment CBAY

review the fundamentals of CymaBay Therapeutics shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

current DY: 0.00%

5-year average DY: 0.00%

ABOUT CymaBay Therapeutics

CymaBay Therapeutics Inc.

United States

38 years

2014

44

PROFIT X PRICE CBAY

Financial Results CBAY

CBAY cash flow

Asset, Revenue and Profit Growth - CBAY

CBAY balance sheet

CI - Cigna

CVS - CVS Health

CNC - Centene

HUM - Humana

SNY - Sanofi

LLY - Eli Lilly

HCA - HCA Healthcare

NVS - Novartis

CI - Cigna

CVS - CVS Health

CNC - Centene

HUM - Humana

SNY - Sanofi

LLY - Eli Lilly

HCA - HCA Healthcare

NVS - Novartis

Frequently Asked Questions